Sara Migliarini

Dr. Sara Migliarini

University of Pisa, Pisa, Tuscany, Italy
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2012 in Molecular Psychiatry
Verified
Journal Article
Closed access
SMSara Migliarini
Sara Migliarini
GPG Pacini
G Pacini
BPB Pelosi
B Pelosi
GLG Lunardi
G Lunardi
MPMassimo Pasqualetti
Massimo Pasqualetti

1 October 2017 in Cell Reports
Verified
Journal Article
Open access
AGAndrea Giorgi
Andrea Giorgi
SMSara Migliarini
Sara Migliarini
AGAlberto Galbusera
Alberto Galbusera
GMGiacomo Maddaloni
Giacomo Maddaloni
MMMaddalena Mereu
Maddalena Mereu
MPMassimo Pasqualetti
Massimo Pasqualetti
Serotonin-producing neurons profusely innervate brain regions via long-range projections. However, it remains unclear whether and how endogenous serotonergic transmission specifically influences regional or global functional activity. We combined designed receptors exclusively activated by designed drugs (DREADD)-based chemogenetics and functional magnetic resonance imaging (fMRI), an approach we term "chemo-fMRI," to causally probe the brain-wide substrates modulated by endogenous serotonergic activity. We describe the generation of a conditional knockin mouse line that, crossed with serotonin-specific Cre-recombinase mice, allowed us to remotely stimulate serotonergic neurons during fMRI scans. We show that endogenous stimulation of serotonin-producing neurons does not affect global brain activity but results in region-specific activation of a set of primary target regions encompassing corticohippocampal and ventrostriatal areas. By contrast, pharmacological boosting of serotonin levels produced widespread fMRI deactivation, plausibly reflecting the mixed contribution of central and perivascular constrictive effects. Our results identify the primary functional targets of endogenous serotonergic stimulation and establish causation between activation of serotonergic neurons and regional fMRI signals.

14 July 2017 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
GMGiacomo Maddaloni
Giacomo Maddaloni
ABAlice Bertero
Alice Bertero
MPMarta Pratelli
Marta Pratelli
NBNoemi Barsotti
Noemi Barsotti
ABAnnemarie Boonstra
Annemarie Boonstra
MPMassimo Pasqualetti
Massimo Pasqualetti
Serotonin-synthetizing neurons, which are confined in the raphe nuclei of the rhombencephalon, provide a pervasive innervation of the central nervous system and are involved in the modulation of a plethora of functions in both developing and adult brain. Classical studies have described the post-natal development of serotonergic axons as a linear process of terminal field innervation. However, technical limitations have hampered a fine morphological characterization. With the advent of genetic mouse models, the possibility to label specific neuronal populations allowed the rigorous measurement of their axonal morphological features as well as their developmental dynamics. Here, we used the Tph2GFP knock-in mouse line, in which GFP expression allows punctual identification of serotonergic neurons and axons, for confocal microscope imaging and we performed 3-dimensional reconstruction in order to morphologically characterize the development of serotonergic fibers in specified brain targets from birth to adulthood. Our analysis highlighted region-specific developmental patterns of serotonergic fiber density ranging from a linear and progressive colonization of the target (Caudate Putamen, Basolateral Amygdala, Geniculate Nucleus and Substantia Nigra) to a transient increase in fiber density (medial Prefrontal Cortex, Globus Pallidus, Somatosensory Cortex and Hippocampus) occurring with a region-specific timing. Despite a common pattern of early post-natal morphological maturation in which a progressive rearrangement from a dot-shaped to a regular and smooth fiber morphology was observed, starting from post-natal day 28 serotonergic fibers acquire the region specific morphological features present in the adult. In conclusion, we provided novel, target-specific insights on the morphology and temporal dynamics of the developing serotonergic fibers.

19 August 2014 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MSM Squillace
M Squillace
LDL Dodero
L Dodero
MFMassimo Federici
Massimo Federici
SMSara Migliarini
Sara Migliarini
Francesco ErricoFrancesco Errico
Francesco Errico
AGA Gozzi
A Gozzi
Autism spectrum disorders (ASD) are neurodevelopmental conditions characterized by pronounced social and communication deficits and stereotyped behaviours. Recent psychosocial and neuroimaging studies have highlighted reward-processing deficits and reduced dopamine (DA) mesolimbic circuit reactivity in ASD patients. However, the neurobiological and molecular determinants of these deficits remain undetermined. Mouse models recapitulating ASD-like phenotypes could help generate hypotheses about the origin and neurophysiological underpinnings of clinically relevant traits. Here we used functional magnetic resonance imaging (fMRI), behavioural and molecular readouts to probe dopamine neurotransmission responsivity in BTBR T+ Itpr3tf/J mice (BTBR), an inbred mouse line widely used to model ASD-like symptoms owing to its robust social and communication deficits, and high level of repetitive stereotyped behaviours. C57BL/6J (B6) mice were used as normosocial reference comparators. DA reuptake inhibition with GBR 12909 produced significant striatal DA release in both strains, but failed to elicit fMRI activation in widespread forebrain areas of BTBR mice, including mesolimbic reward and striatal terminals. In addition, BTBR mice exhibited no appreciable motor responses to GBR 12909. DA D1 receptor-dependent behavioural and signalling responses were found to be unaltered in BTBR mice, whereas dramatic reductions in pre- and postsynaptic DA D2 and adenosine A2A receptor function was observed in these animals. Overall these results document profoundly compromised DA D2-mediated neurotransmission in BTBR mice, a finding that is likely to have a role in the distinctive social and behavioural deficits exhibited by these mice. Our results call for a deeper investigation of the role of dopaminergic dysfunction in mouse lines exhibiting ASD-like phenotypes, and possibly in ASD patient populations.

1 May 2018 in Neuron
Verified
Journal Article
Closed access
ACAnna Cavaccini
Anna Cavaccini
MGMarta Gritti
Marta Gritti
AGAndrea Giorgi
Andrea Giorgi
ALAndrea Locarno
Andrea Locarno
NHNicolas Heck
Nicolas Heck
RTRaffaella Tonini
Raffaella Tonini

9 March 2016 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DPDaniela Punzo
Daniela Punzo
Francesco ErricoFrancesco Errico
Francesco Errico
LCLuigia Cristino
Luigia Cristino
Silvia SacchiSilvia Sacchi
Silvia Sacchi
SKSimona Keller
Simona Keller
Alessandro UsielloAlessandro Usiello
Alessandro Usiello
The endogenous NMDA receptor (NMDAR) agonistd-aspartate occurs transiently in the mammalian brain because it is abundant during embryonic and perinatal phases before drastically decreasing during adulthood. It is well established that postnatal reduction of cerebrald-aspartate levels is due to the concomitant onset ofd-aspartate oxidase (DDO) activity, a flavoenzyme that selectively degrades bicarboxylicd-amino acids. In the present work, we show thatd-aspartate content in the mouse brain drastically decreases after birth, whereasDdomRNA levels concomitantly increase. Interestingly, postnatalDdogene expression is paralleled by progressive demethylation within its putative promoter region. Consistent with an epigenetic control onDdoexpression, treatment with the DNA-demethylating agent, azacitidine, causes increased mRNA levels in embryonic cortical neurons. To indirectly evaluate the effect of a putative persistentDdogene hypermethylation in the brain, we usedDdoknock-out mice (Ddo−/−), which show constitutively suppressedDdoexpression. In these mice, we found for the first time substantially increased extracellular content ofd-aspartate in the brain. In line with detrimental effects produced by NMDAR overstimulation, persistent elevation ofd-aspartate levels inDdo−/−brains is associated with appearance of dystrophic microglia, precocious caspase-3 activation, and cell death in cortical pyramidal neurons and dopaminergic neurons of the substantia nigra pars compacta. This evidence, along with the early accumulation of lipufuscin granules inDdo−/−brains, highlights an unexpected importance ofDdodemethylation in preventing neurodegenerative processes produced by nonphysiological extracellular levels of freed-aspartate.SIGNIFICANCE STATEMENTThe enzymed-aspartate oxidase (DDO) catalyzes the degradation of the NMDA receptor agonist,d-aspartate. In the brain, DDO is expressed only during postnatal life, thus reducing the embryonic storage ofd-aspartate and keeping thisd-amino acid at low levels during adulthood. Although the presence of DDO in mammals is long established, its biological role in the brain and the mechanism regulating its expression are still unclear. Here, we found thatDdopromoter demethylation enables the postnatal expression ofDdo. Moreover, persistent suppression ofDdoexpression leads to persistent spillover of extracellulard-aspartate and produces precocious cell death in the mouse brain, thus suggesting a key role for DDO in preventing early neurodegeneration triggered by excessive NMDA receptor stimulation.